The All Breast Cancer in Malmö (ABiM) study, a well-characterized, population-based, prospectively collected cohort of 273 breast cancer patients, diagnosed during the period of 2007–2009 at a single institution, was retrospectively analyzed for the presence of germline BRCA1 and BRCA2 mutations. The gene discussed is BRCA2; the disease is breast carcinoma.